Single-agent capecitabin maintenance therapy after induction of XELOX (or FOLFOX) in first-line treatment of metastatic colorectal cancer

被引：0
|
作者：
Xu, R. [1 ]
Yuhong, L. [1 ]
Huiyan, L. [1 ]
Wei, W. [2 ]
Zhiqiang, W. [1 ]
Xia, Y. [3 ]
Dong, M. [4 ]
Hua, W. Feng [1 ]
Dongsheng, Z. [1 ]
Daren, L. [5 ]
Chen, L. Yin [6 ]
Jun, J. [7 ]
Hua, H. Xiao [8 ]
Wen, P. Jie [9 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Med Oncol, Guangzhou 510275, Guangdong, Peoples R China
[2] First Peoples Hosp Foshan, Med Oncol, Foshan, Peoples R China
[3] Huizhou Cent Hosp, Med Oncol, Huizhou, Peoples R China
[4] Guangdong Gen Hosp, Med Oncol, Guangzhou, Guangdong, Peoples R China
[5] Jiangmen Cent Hosp, Med Oncol, Jiangmen, Peoples R China
[6] Shantou Univ, Coll Med, Canc Hosp, Med Oncol, Shantou, Peoples R China
[7] Dongguan Peoples Hosp, Med Oncol, Dongguan, Peoples R China
[8] Guangxi Med Univ, Tumor Hosp, Med Oncol, Nanning, Peoples R China
[9] Zhongshan Peoples Hosp, Med Oncol, Zhongshan, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31049-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2127
引用
收藏
页码：S373 / S374
页数：2
相关论文
共 50 条
  • [41] Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study
    Antonuzzo, Lorenzo
    Giommoni, Elisa
    Pastorelli, Davide
    Latiano, Tiziana
    Pavese, Ida
    Azzarello, Domenico
    Aieta, Michele
    Pastina, Ilaria
    Di Fabio, Francesca
    Bertolini, Alessandro
    Corsi, Domenico Cristiano
    Mogavero, Selene
    Angelini, Valentina
    Pazzagli, Mario
    Di Costanzo, Francesco
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (23) : 7281 - 7288
  • [42] A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer
    Gravalos, Cristina
    Carrato, Alfredo
    Tobena, Maria
    Rodriguez-Garrote, Mercedes
    Soler, Gemma
    Ma Vieitez, Jose
    Robles, Luis
    Valladares-Ayerbes, Manuel
    Polo, Eduardo
    Luisa Limon, Ma
    Jose Safont, Ma
    Martinez de Castro, Eva
    Garcia-Alfonso, Pilar
    Aranda, Enrique
    CLINICAL COLORECTAL CANCER, 2018, 17 (02) : E323 - E329
  • [43] The efficiency of FOLFOX and XELOX application as a first-line chemotherapy of the advanced colorectal cancer patients
    Zeynalov, R.
    Musayev, I
    Gasanzadeh, J.
    Ahadova, N.
    Dadasheva, N.
    ANNALS OF ONCOLOGY, 2006, 17 : 81 - 81
  • [44] ESTIMATION OF COSTS OF FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER (MCRC) WITH FOLFIRI, FOLFOX OR XELOX PLUS BEVACIZUMAB, IN FIVE MEXICAN INSTITUTIONS
    Calderillo, Ruiz G.
    VALUE IN HEALTH, 2011, 14 (07) : A539 - A539
  • [45] XELOX (capecitabine plus oxaliplatin):: Active first-line therapy for patients with metastatic colorectal cancer
    Cassidy, J
    Tabernero, J
    Twelves, C
    Brunet, R
    Butts, C
    Conroy, T
    Debraud, F
    Figer, A
    Grossmann, J
    Sawada, N
    Schöffski, P
    Sobrero, A
    Van Cutsem, E
    Diaz-Rubio, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2084 - 2091
  • [46] Comparative analysis of different maintenance regimens after first-line induction in patients with metastatic colorectal cancer
    Mohamed, A. M. R.
    Abdallah, Nadine
    Ismail, Hibah
    Chen, Wei
    Jang, Hyejeong
    Smith, Daryn W.
    Akhras, Alaa
    Tesfaye, Anteneh A.
    Philip, Philip Agop
    Shields, Anthony Frank
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [47] FOLFOX alternated with FOLFIRI as first-line chemotherapy for metastatic colorectal cancer
    Aparicio, Jorge
    Fernandez-Martos, Carlos
    Vicent, Jose M.
    Maestu, Inmaculada
    Llorca, Cristina
    Busquier, Isabel
    Campos, Jan M.
    Perez-Enguix, Daniel
    Balcells, Miquel
    CLINICAL COLORECTAL CANCER, 2005, 5 (04) : 263 - 267
  • [48] First-line, single-agent Herceptin® (trastuzumab) in metastatic breast cancer:: a preliminary report
    Vogel, C
    Cobleigh, MA
    Tripathy, D
    Gutheil, JC
    Harris, LN
    Fehrenbacher, L
    Slamon, DJ
    Murphy, M
    Novotny, WF
    Burchmore, M
    Shak, S
    Stewart, SJ
    EUROPEAN JOURNAL OF CANCER, 2001, 37 : S25 - S29
  • [49] Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer
    Grande, Carlos
    Quintero, Guillermo
    Candamio, Sonia
    Paris Bouzas, Lorena
    Jose Villanueva, Maria
    Campos, Begona
    Gallardo, Elena
    Alvarez, Elena
    Casal, Joaquin
    Ramon Mel, Jose
    JOURNAL OF GERIATRIC ONCOLOGY, 2013, 4 (02) : 114 - 121
  • [50] Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer
    Arteaga, CL
    BREAST CANCER RESEARCH, 2003, 5 (02) : 96 - 100
12345